Discontinuation report LIVOSTIN SUS NAS 0.5MG/ML
| Report ID | 117970 |
| Drug Identification Number | 02020017 |
| Brand name | LIVOSTIN SUS NAS 0.5MG/ML |
| Common or Proper name | LIVOSTIN |
| Company Name | JANSSEN INC |
| Market Status | MARKETED |
| Active Ingredient(s) | LEVOCABASTINE |
| Strength(s) | 0.05MG |
| Dosage form(s) | SUSPENSION SPRAY |
| Route of administration | NASAL NASAL |
| Packaging size | 1x1 |
| ATC code | R01AC |
| ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2021-01-01 |
| Actual discontinuation date | 2021-01-12 |
| Remaining supply date | 2020-12-24 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Contact Address | 19 GREEN BELT DRIVE TORONTO, ONTARIO CANADA M3C 1L9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.